A Facebook ad seeks people already on semaglutide or tirzepatide to test a once-monthly GLP-1 drug. It gives no sponsor or results.
Recap by typeshit. Post by Facebook on Facebook.
A Facebook post says US researchers found pancreatic cells producing GLP-1 on their own. It frames this as a possible built-in appetite and sugar control system, without naming the study.
Researchers are studying whether GLP-1 drugs, which act on mood, appetite and reward pathways, could help with depression, addiction and binge eating.
A retrospective cohort checks whether retinal disease started or worsened more in established users than in people never on either drug, plus a regional NAION review.
24:34
An animated explainer walking through what semaglutide does in the body, from appetite signals in the brain to digestion and blood sugar control.
Chosun Ilbo got a look inside the plant, where AI systems and robots run much of the Wegovy production line.
The Swiss drugmaker is buying rights to the Chinese biotech's experimental drug as it tries to catch Eli Lilly and Novo Nordisk in obesity.
Loading…